SENS PubMed Publication Search
Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: Its potential role in prompt recognition of diabetes mellitus auto-antibodies.
Chem Biol Interact. 2014 Jun 23;219C:229-240. doi: 10.1016/j.cbi.2014.06.012
Shahab U, Tabrez S, Khan MS, Akhter F, Khan MS, Saeed M, Ahmad K, Srivastava AK, Ahmad S
Abstract:
.....The present study reports the genotoxicity and immunogenicity of AGEs formed by Glyoxal-Arginine-Fe3+ (G-Arg-Fe3+) system as a glycating agent. Immunogenicity of native and G-Arg-Fe3+-DNA was probed in female rabbits. Immunofluorescence suggests the presence of immune complex deposition in the kidney section of immunized rabbits. Spectroscopic analysis and melting temperature indicates the structural modification in the human DNA. The modified human DNA is found to be highly immunogenic, whereas unmodified form was simply non-immunogenic. This study shows the presence of auto-antibodies against G-Arg-Fe3+ modified human DNA in the sera of diabetes type 1 and in few cases type 2 patients due to secondary complications of nephropathy. The glyco-oxidative lesions have also been detected in the lymphocyte DNA isolated from patients having type 1 and type 2 diabetes. The results show structural perturbations generating new epitopes in G-Arg-Fe3+-DNA rendering it pretty immunogenic.
PMID: 24968179
Tags: AGEs, DNA adducts, type 2 diabetes